| Characteristic | Traditional Chinese Medicine | Western Drugs |
|---|---|---|
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Sources
Release date
May 2011
More information
Region
China
Survey time period
2009
Supplementary notes
* The National Reimbursement Drug List (NRDL) provides the reimbursement framework for the 'urban employee basic medical insurance (BMI) scheme' and 'urban resident BMI scheme'.
** A List: Generic, low-cost products, fully reimbursable; decided by central government.
*** B list: Name brand products, generally higher in price. Compound drugs not listed in the NRDL, but made up by NRDL-listed drugs are reimbursable as List B drugs as long as the compound's price is not higher than the sum of its ingredient drugs.
Citation formats
